Under the 2021 WHO classification, a diagnosis of glioblastoma (CNS WHO grade 4) requires the tumor to be a diffuse astrocytic glioma that is IDH (isocitrate dehydrogenase) gene (without a mutation in the IDH1 or IDH2 genes) (Park et al., 2023). This evidence concerns the gene IDH2 and neoplasm.